|
|
|
Hormone Replacement Therapy
(ARA) – Given all the bad news about Hormone Replacement Therapy (HRT), now there’s some good news on how menopausal and post-menopausal women can live productive, healthy lives.
Millions of women took HRT to preserve bone health and brain...
Zometa and Aredia Warning. Victim Compensation
2005 Zometa, Aredia,Fosamax Side Effects Warning Fosamax generic name Alendronate ,Zometa and Aredia are types of drugs known as bisphosphonates Recently a link has been found between bisphosphonates and a serious bone disease called osteonecrosis...
Menopause and Progesterone
Do women going through menopause have lowered levels of progesterone? Recent research tells us that women do suffer from decreased levels of progesterone and also experience other symptoms such as unexplained weight gain (particularly in the...
Be Healthier and More Productive with Positive Habits
The Power of Positive Habits
Did you know that habits are incredibly powerful tools for personal growth and success?
Think about the habits you have now and how they affect virtually every aspect of your life. Your weight and health are...
Women and heart disease:
How do you start to transform the long ingrained opinions that heart disease affects primarily men? Most people are surprised when told that not only is heart disease the #1 killer of women, but that more women die from heart disease than breast...
|
|
| |
|
|
|
|
Recommendations For Early Breast Cancer Screening
Women need to empower themselves about the benefits and risks of mammography and examine the additional screening tools available today. One current philosophy suggests breast health screening should begin at age 25. Where does this recommendation come from and why is this valid?
For MOST women, the recommendation for annual breast cancer screening begins at the age of 40. Unfortunately, the American Cancer Society stated that the number one cause of death in women between the ages of 40-44 is breast cancer. So what does this mean for women? It means that we screen at age 40 and potentially find tumors that have been growing for an estimated 8-10 years. Mammography, like most conventional tests, evaluates structure.
There exists a technology that can detect an issue YEARS before a tumor can be seen on X-ray or palpated during an exam. This technology has been approved by the FDA as an adjunctive screening tool since 1982 and offers NO RADIATION, NO COMPRESSION AND NO PAIN. For women who are refusing to have a mammogram or those who want clinical correlation for an existing problem, digital infrared thermal imaging may be of interest.
There are very strict protocols both for testing and interpreting. Perhaps due to these guidelines, thermography (as with all digital technology) has exploded in its technique and capabilities. Thermal cameras detect heat emitted from the body and display it as a picture on a computer monitor. These images are unique to the person and remain stable over time. It is because of these characteristics that thermal imaging is a valuable and effective screening tool. Tumors or other breast diseases measures warmer than surrounding tissue and can thereby alert a physician to a problem before a tumor is actually palpable.
Medical doctors who interpret the breast
scans are board certified and endure an additional two years of training to qualify as a thermologist. Thermography is not limited by breast density and is ideal for women who have had cosmetic or reconstructive surgery. It is recommended that since cancer typically has a 15 year life span from onset to death, women begin thermographic screenings at age 25. As previously mentioned, the number one killer of women ages 40-44 is breast cancer. Therefore, a woman diagnosed with breast cancer at age 40 possibly had the cancer as early as age 30. Since most women do not have a mammogram until age 40, there is a critical time period from age 25 to 39 that thermography could be especially beneficial. Thermography, because it analyzes function, may identify a problem years earlier. DITI may allow women time and opportunity to support their immune system, change their lifestyle and give their body the best chance to alter their fate.
By combining both technologies, the detection rate increases to 95-98%, surpassing either technology as a stand-alone therapy. Thermography, like mammography, is a personal choice for women. This decision ideally should be made in collaboration between you and your physician. However, thermography does not require a physician's order.
Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to www.proactivehealthonline.com.
About the Author
Brenda Witt is co-owner of Proactive Health Solutions in Southern California. She has worked in the medical field for 9 years and is now an American College of Clinical Thermology (ACCT) certified thermographer in the Orange County area. To contact Brenda, email her at brenda@proactivehealthonline.com.
|
|
|
|
|
|